AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH UNMANIPULATED G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELL PREPARATION
Authors: SIEGERT W BEYER J KINGREEN D BLASCZYK R BAURMANN H SCHWELLA N SCHLEICHER J KIRSCH A HUHN D
Citation: W. Siegert et al., TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH UNMANIPULATED G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELL PREPARATION, Bone marrow transplantation, 22(6), 1998, pp. 579-583
CURRENT TREATMENT RESULTS AND FUTURE INDICATIONS FOR HIGH-DOSE CHEMOTHERAPY IN GERM-CELL TUMORS
Authors: SIEGERT W RICK O BEYER J SCHWELLA N SCHLEICHER J HUHN D
Citation: W. Siegert et al., CURRENT TREATMENT RESULTS AND FUTURE INDICATIONS FOR HIGH-DOSE CHEMOTHERAPY IN GERM-CELL TUMORS, Bone marrow transplantation, 22, 1998, pp. 15-15
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS BY DISEASE-SPECIFICCHEMOTHERAPY IN PATIENTS WITH SOFT-TISSUE SARCOMA
Authors: SCHWELLA N RICK O MEYER O LOFFEL J SCHLEICHER J SERKE S HUHN D RIESS H
Citation: N. Schwella et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS BY DISEASE-SPECIFICCHEMOTHERAPY IN PATIENTS WITH SOFT-TISSUE SARCOMA, Bone marrow transplantation, 21(9), 1998, pp. 863-868
LONG-TERM SURVIVAL AFTER HIGH-DOSE SALVAGE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL TUMORS
Authors: RICK O BEYER J SCHWELLA N KINGREEN D KIRSCH A SCHLEICHER J KRUSCH A HUHN D SIEGERT W
Citation: O. Rick et al., LONG-TERM SURVIVAL AFTER HIGH-DOSE SALVAGE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL TUMORS, Bone marrow transplantation, 21, 1998, pp. 799-799
EPIDEMIOLOGIC AND CLINICAL ASPECTS OF HEPATITIS-G VIRUS-INFECTION IN BLOOD-DONORS AND IMMUNOCOMPROMISED RECIPIENTS OF HGV-CONTAMINATED BLOOD
Authors: HEUFT HG BERG T SCHREIER E KUNKEL U TACKE M SCHWELLA N HOPF U SALAMA A HUHN D
Citation: Hg. Heuft et al., EPIDEMIOLOGIC AND CLINICAL ASPECTS OF HEPATITIS-G VIRUS-INFECTION IN BLOOD-DONORS AND IMMUNOCOMPROMISED RECIPIENTS OF HGV-CONTAMINATED BLOOD, Vox sanguinis, 74(3), 1998, pp. 161-167
BACTERIAL-CONTAMINATION OF AUTOLOGOUS BONE-MARROW - REINFUSION OF CULTURE-POSITIVE GRAFTS DOES NOT RESULT IN CLINICAL SEQUELAE DURING THE POSTTRANSPLANTATION COURSE
Authors: SCHWELLA N RICK O HEUFT HG MIKSITS K ZIMMERMANN R ZINGSEM J ECKSTEIN R HUHN D
Citation: N. Schwella et al., BACTERIAL-CONTAMINATION OF AUTOLOGOUS BONE-MARROW - REINFUSION OF CULTURE-POSITIVE GRAFTS DOES NOT RESULT IN CLINICAL SEQUELAE DURING THE POSTTRANSPLANTATION COURSE, Vox sanguinis, 74(2), 1998, pp. 88-94
ANALYSIS OF CD34-EXPRESSING CELLS IN CLINICAL-PRACTICE
Authors: SERKE S BEYER J RICK O SCHWELLA N MEYER O HILDEBRANDT M HUHN D
Citation: S. Serke et al., ANALYSIS OF CD34-EXPRESSING CELLS IN CLINICAL-PRACTICE, Vox sanguinis, 74, 1998, pp. 469-475
LONG-TERM SURVIVAL AND LATE TOXICITIES AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS SUFFERING FROM GERM-CELL CANCER
Authors: RICK O BEYER J SCHWELLA N KINGREEN D KRUSCH A HUHN D SIEGERT W
Citation: O. Rick et al., LONG-TERM SURVIVAL AND LATE TOXICITIES AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS SUFFERING FROM GERM-CELL CANCER, European journal of cancer, 33, 1997, pp. 156-156
PREPARATION OF AUTOLOGOUS BONE-MARROW GRAFTS FOR CRYOPRESERVATION USING THE AS104 CELL SEPARATOR
Authors: RICK O HEUFT HG WITTMANN G BLASCZYK R HUHN D SCHWELLA N
Citation: O. Rick et al., PREPARATION OF AUTOLOGOUS BONE-MARROW GRAFTS FOR CRYOPRESERVATION USING THE AS104 CELL SEPARATOR, Journal of clinical apheresis, 12(4), 1997, pp. 179-182
HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH RELAPSED OR REFRACTORY MALIGNANT-LYMPHOMAS - A PHASE I II STUDY/
Authors: KLEINER S KIRSCH A SCHWANER I KINGREEN D SCHWELLA N HUHN D SIEGERT W
Citation: S. Kleiner et al., HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH RELAPSED OR REFRACTORY MALIGNANT-LYMPHOMAS - A PHASE I II STUDY/, Bone marrow transplantation, 20(11), 1997, pp. 953-959
PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION DURING HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION
Authors: SCHWELLA N KINGREEN D HEUFT HG OETTLE H RICK O SERKE S HUHN D SIEGERT W
Citation: N. Schwella et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION DURING HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION, Vox sanguinis, 72(2), 1997, pp. 118-120
LONG-TERM SURVIVAL OF PATIENTS WITH RECURRENT OR REFRACTORY GERM-CELLTUMORS AFTER HIGH-DOSE CHEMOTHERAPY
Authors: BEYER J KINGREEN D KRAUSE M SCHLEICHER J SCHWANER I SCHWELLA N HUHN D SIEGERT W
Citation: J. Beyer et al., LONG-TERM SURVIVAL OF PATIENTS WITH RECURRENT OR REFRACTORY GERM-CELLTUMORS AFTER HIGH-DOSE CHEMOTHERAPY, Cancer, 79(1), 1997, pp. 161-168
IMPACT OF PRELEUKAPHERESIS CELL COUNTS ON COLLECTION RESULTS AND CORRELATION OF PROGENITOR-CELL DOSE WITH ENGRAFTMENT AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL CANCER
Authors: SCHWELLA N BEYER J SCHWANER I HEUFT HG RICK O HUHN D SERKE S SIEGERT W
Citation: N. Schwella et al., IMPACT OF PRELEUKAPHERESIS CELL COUNTS ON COLLECTION RESULTS AND CORRELATION OF PROGENITOR-CELL DOSE WITH ENGRAFTMENT AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1114-1121
DISCRIMINATION OF HLA-B27 ALLELES BY GROUP-SPECIFIC AMPLIFICATION FOLLOWED BY SOLID-PHASE SEQUENCING
Authors: BLASCZYK R WEBER M VANLESSEN A SCHWELLA N HUHN D SALAMA A
Citation: R. Blasczyk et al., DISCRIMINATION OF HLA-B27 ALLELES BY GROUP-SPECIFIC AMPLIFICATION FOLLOWED BY SOLID-PHASE SEQUENCING, Human immunology, 45(2), 1996, pp. 117-123
ANALYSIS FOR RECOVERY AND LOSS OF MONONUCLEAR-CELLS AND COLONY-FORMING-UNITS GRANULOCYTE-MACROPHAGE DURING EX-VIVO PROCESSING OF AUTOLOGOUSBONE-MARROW
Authors: SCHWELLA N HEUFT HG RICK O BLASCZYK R WITTMANN G HUHN D
Citation: N. Schwella et al., ANALYSIS FOR RECOVERY AND LOSS OF MONONUCLEAR-CELLS AND COLONY-FORMING-UNITS GRANULOCYTE-MACROPHAGE DURING EX-VIVO PROCESSING OF AUTOLOGOUSBONE-MARROW, Vox sanguinis, 70(3), 1996, pp. 132-138
IN-VITRO CLONOGENICITY OF MOBILIZED PERIPHERAL-BLOOD CD34-EXPRESSING CELLS - INVERSE CORRELATION TO BOTH RELATIVE AND ABSOLUTE NUMBERS OF CD34-EXPRESSING CELLS
Authors: SERKE S WATTS M KNUDSEN LM KREISSIG C SCHNEIDER U SCHWELLA N LINCH D JOHNSEN HE
Citation: S. Serke et al., IN-VITRO CLONOGENICITY OF MOBILIZED PERIPHERAL-BLOOD CD34-EXPRESSING CELLS - INVERSE CORRELATION TO BOTH RELATIVE AND ABSOLUTE NUMBERS OF CD34-EXPRESSING CELLS, British Journal of Haematology, 95(2), 1996, pp. 234-240
AUTOGRAFTING WITH BLOOD PROGENITOR CELLS - PREDICTIVE VALUE OF PREAPHERESIS BLOOD-CELL COUNTS ON PROGENITOR-CELL HARVEST AND CORRELATION OFTHE REINFUSED CELL DOSE WITH HEMATOPOIETIC RECONSTITUTION
Authors: SCHWELLA N SIEGERT W BEYER J RICK O ZINGSEM J ECKSTEIN R SERKE S HUHN D
Citation: N. Schwella et al., AUTOGRAFTING WITH BLOOD PROGENITOR CELLS - PREDICTIVE VALUE OF PREAPHERESIS BLOOD-CELL COUNTS ON PROGENITOR-CELL HARVEST AND CORRELATION OFTHE REINFUSED CELL DOSE WITH HEMATOPOIETIC RECONSTITUTION, Annals of hematology, 71(5), 1995, pp. 227-234
HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY USING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS OR BONE-MARROW - A RANDOMIZED COMPARISON
Authors: BEYER J SCHWELLA N ZINGSEM J STROHSCHEER I SCHWANER I OETTLE H SERKE S HUHN D SIEGERT W
Citation: J. Beyer et al., HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY USING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS OR BONE-MARROW - A RANDOMIZED COMPARISON, Journal of clinical oncology, 13(6), 1995, pp. 1328-1335
A NOVEL HLA-DR13 ALLELE (DRB1-ASTERISK-1314) IDENTIFIED BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS AND CONFIRMED BY DIRECT SEQUENCING
Authors: BLASCZYK R VANLESSEN A SCHWELLA N HUHN D SALAMA A
Citation: R. Blasczyk et al., A NOVEL HLA-DR13 ALLELE (DRB1-ASTERISK-1314) IDENTIFIED BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS AND CONFIRMED BY DIRECT SEQUENCING, Human immunology, 43(4), 1995, pp. 309-312
IDENTIFICATION OF A NOVEL HLA-A33 SUBTYPE (A-ASTERISK-3303) AND CORRECTION OF THE A-ASTERISK-3301 SEQUENCE
Authors: BLASCZYK R WEHLING J HAHN U SCHWELLA N HUHN D SALAMA A
Citation: R. Blasczyk et al., IDENTIFICATION OF A NOVEL HLA-A33 SUBTYPE (A-ASTERISK-3303) AND CORRECTION OF THE A-ASTERISK-3301 SEQUENCE, Tissue antigens, 45(5), 1995, pp. 348-352
HLA-DPB1 TYPING BY PCR-SSO REVERSE DOT-BL OT HYBRIDIZATION AFTER GROUP-SPECIFIC AMPLIFICATION
Authors: BLASCZYK R MOHR M ZIMMERMANN R SCHWELLA N HUHN D
Citation: R. Blasczyk et al., HLA-DPB1 TYPING BY PCR-SSO REVERSE DOT-BL OT HYBRIDIZATION AFTER GROUP-SPECIFIC AMPLIFICATION, Infusionstherapie und Transfusionsmedizin, 21(6), 1994, pp. 401-404
ONDANSETRON FOR EFFICIENT EMESIS CONTROL DURING TOTAL-BODY IRRADIATION
Authors: SCHWELLA N KONIG V SCHWERDTFEGER R SCHMIDTWOLF I SCHMID H RIESS H SIEGERT W
Citation: N. Schwella et al., ONDANSETRON FOR EFFICIENT EMESIS CONTROL DURING TOTAL-BODY IRRADIATION, Bone marrow transplantation, 13(2), 1994, pp. 169-171
MICROBIOLOGIC CONTAMINATION OF PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS
Authors: SCHWELLA N ZIMMERMANN R HEUFT HG BLASCZYK R BEYER J RICK O KREISSIG C ZINGSEM J ECKSTEIN R SIEGERT W
Citation: N. Schwella et al., MICROBIOLOGIC CONTAMINATION OF PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS, Vox sanguinis, 67(1), 1994, pp. 32-35
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENCE OF LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: SCHWELLA N SCHWERDTFEGER R KONIG V BLASCZYK R SCHMID H SCHMIDTWOLF I HENZE G SIEGERT W
Citation: N. Schwella et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENCE OF LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Transplantation, 57(8), 1994, pp. 1263-1265
RECOVERY AND LOSS OF MONONUCLEAR-CELLS AND COLONY-FORMING-UNITS DURING AUTOMATED PROCESSING OF AUTOLOGOUS BONE-MARROW
Authors: HEUFT HG SCHWELLA N BLASCZYK R WITTMANN G HUHN D
Citation: Hg. Heuft et al., RECOVERY AND LOSS OF MONONUCLEAR-CELLS AND COLONY-FORMING-UNITS DURING AUTOMATED PROCESSING OF AUTOLOGOUS BONE-MARROW, Transfusion, 34(10), 1994, pp. 190000004-190000004
Risultati: 1-25 | 26-30